Chugai Pharmaceutical Co., Ltd.
4519
Clasificación en acciones
#358
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Precio por acción
$41.17
Capitalización bursátil
$67.75B
Cambio (1 día)
-0.68%
Cambio (1 año)
-15.27%
País
JP
Comercio Chugai Pharmaceutical Co., Ltd. (4519)
Categoría
Healthcare
Capitalización de mercado de Chugai Pharmaceutical Co., Ltd.(4519)
Capitalización bursátil: $67.75B
A fecha de October 2026, Chugai Pharmaceutical Co., Ltd. tiene una capitalización de mercado de $67.75B. Esto convierte a Chugai Pharmaceutical Co., Ltd. en la 358th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Chugai Pharmaceutical Co., Ltd. desde 2000 hasta 2026
4519 en comparación con los más populares 5 títulos stocks
